Back to company

ELDON BIOLOGICALS A/S: Financial statements 2020

CVR: 26747007

ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 14,331,404 and a net result of DKK 6,608,688 compared with DKK 3,309,735 the year before. That is an increase of 50.3% compared with the year before. Equity amounted to DKK 16,549,055. The solvency ratio was 75.3%. The company had 8 employees in the financial year.

Gross Profit
14,331,404 kr.
Profit/Loss
6,608,688 kr.
Equity
16,549,055 kr.
Total Assets
21,971,570 kr.
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-14.3 mio.6.6 mio.16.5 mio.8
2019-9.5 mio.3.3 mio.10.5 mio.6
2018-9.5 mio.3.8 mio.7.1 mio.7
2017-8 mio.2.6 mio.3.9 mio.7
2016-6.1 mio.1.2 mio.1.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ELDON BIOLOGICALS A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Kasper Juul Hedegaard joins ELDON BIOLOGICALS A/S as adm. dir.Dec 1, 2020

As of December 1, 2020, Kasper Juul Hedegaard is registered as adm. dir. of ELDON BIOLOGICALS A/S.

Hans-Ole Hedegaard steps down as director of ELDON BIOLOGICALS A/SDec 1, 2020

As of December 1, 2020, Hans-Ole Hedegaard has stepped down as director of ELDON BIOLOGICALS A/S.

About ELDON BIOLOGICALS A/S

ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.